Novartis Venture Fund
-
Type of investor
CVC -
Based in
Basel -
Number of investments
10+ -
Industry
biotech, medtechVisit website of
Novartis Venture Fund
Related News
25.04.2025 15:22
Granite Bio debuts with $100 million to tackle autoimmune diseases
03.03.2023 13:27
Oculis goes public on Nasdaq
18.10.2022 17:00
Oculis to go public via SPAC
16.12.2021 08:51
Anaveon raises CHF 110 million
07.05.2021 14:06
Oculis closes US$57 million Series C financing
22.04.2020 15:21
Basel-based FoRx Therapeutics secures EUR 10 million seed round
13.09.2019 11:49
Anokion raises $40 million and acquires US biotech startup
05.06.2019 10:55
The UZH Life Sciences Fund investS CHF1M in an anti-obesity drug
05.01.2018 13:54
Oculis raises CHF20 million and moves to Switzerland
16.06.2015 17:01
MyoPowers raises € 4.5M and moves to France
25.08.2014 16:44
Janssen Affiliate Cilag GmbH International Acquires Covagen AG
09.12.2013 18:05
Covagen Secures CHF 42 Million in Series B Financing
The new Swiss Venture Capital Report was published on 26 January. It analyses 304 financing rounds closed in 2020 and includes further article such as an interview with Michael Hengartner, President of the ETH Board, and a list of Swiss "soonicorns". 
